Recombinant Cynomolgus/Rhesus Macaque BTLA Fc Protein, CF

Catalog # Availability Size / Price Qty
10030-BT-050
Recombinant Cynomolgus/Rhesus Macaque BTLA Fc Protein, CF Binding Activity
2 Images
Product Details
FAQs
Reviews

Recombinant Cynomolgus/Rhesus Macaque BTLA Fc Protein, CF Summary

Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its binding ability in a functional ELISA. When Recombinant Mouse HVEM/TNFRSF14 Fc Chimera (Catalog # 2516-HV) is immobilized at 0.5 µg/mL, Recombinant Cynomolgus Monkey BTLA Fc Chimera binds with an ED50 of 25-125 ng/mL.
Source
Human embryonic kidney cell, HEK293-derived BTLA protein
Cynomolgus Monkey BTLA
(Met1-Leu150)
Accession # XP_005548224
IEGRMD Human IgG1
(Pro100-Lys330)
N-terminusC-terminus
Accession #
N-terminal Sequence
Analysis
Lys31
Structure / Form
Disulfide-linked homodimer
Predicted Molecular Mass
40.3 kDa
SDS-PAGE
48-58 kDa, reducing conditions

Product Datasheets

10030-BT

Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Reconstitution Reconstitute at 500 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:
  • 12 months from date of receipt, ≤ -20 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, ≤ -20 °C under sterile conditions after reconstitution.

Data Images

Binding Activity Recombinant Cynomolgus/Rhesus Macaque BTLA Fc Protein, CF Binding Activity View Larger

When Recombinant Mouse HVEM/TNFRSF14 Fc Chimera (Catalog # 2516-HV) is immobilized at 0.5 µg/mL, Recombinant Cynomolgus Monkey BTLA FcChimera binds with an ED50 of 25-125 ng/mL.

SDS-PAGE Recombinant Cynomolgus/Rhesus Macaque BTLA Fc Protein, CF SDS-PAGE View Larger

2 μg/lane of Recombinant Cynomolgus Monkey BTLA was resolved with SDS-PAGE underreducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Bluestaining, showing bands at 48-58 kDa and 100-115 kDa, respectively.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: BTLA

B- and T-lymphocyte attenuator (BTLA; CD272) is a 50-57 kDa type I transmembrane glycoprotein in the CD28 family of T cell co-stimulatory molecules (1-3). Mature cynomolgus BTLA contains a 127 amino acid (aa) extracellular domain (ECD), a 21 aa transmembrane sequence, and a 111 aa cytoplasmic domain. In humans, the cytoplasmic tail transmits inhibitory signaling via two ITIM motifs and three Tyr phosphorylation sites (4, 5). The ECD of cynomolgus BTLA shares 88% aa identity with that of human BTLA. A splice variant lacking the transmembrane domain has been reported in humans (6). Unlike other CD28 family members, the BTLA Ig domain in the ECD is of the I-type rather than V-type, and BTLA does not form homodimers (7). BTLA is also unusual in its interaction with the TNF superfamily member HVEM rather than with B7 family ligands (8). BTLA is expressed on T cells, B cells, macrophages, dendritic cells, and NK cells (9). Its expression is low in naïve T cells and increases during antigen-specific induction of anergy. In B cells, BTLA expression is highest in mature naïve cells (9). BTLA apparently limits T cell numbers, since its deletion results in overproduction of T cells, especially CD8+ memory T cells that are hyper-responsive to TCR cross-linking (10). Under the control of ROR gamma t and IL-7, BTLA regulates the homeostasis and inflammatory responses of gamma δT cells (11). The binding of BTLA and HVEM does not preclude the concurrent binding of other HVEM ligands such as LIGHT or Lymphotoxin-alpha (12).

References
  1. Murphy, K.M. et al. (2006) Nat. Rev. Immunol. 6:671.
  2. Croft, M. (2005) Trends. Immunol. 26:292.
  3. Watanabe, N. et al. (2003) Nat. Immunol. 4:670.
  4. Gavrieli, M. et al. (2003) Biochem. Biophys. Res. Commun. 312:1236.
  5. Chemnitz, J.M. et al. (2006) J. Immunol. 176:6603.
  6. Han, P. et al. (2004) J. Immunol. 172:5931
  7. Compaan, D.M. et al. (2005) J. Biol. Chem. 280:39553.
  8. Sedy, J. R. et al. (2005) Nat. Immunol. 6:90.
  9. Hurchla, M.A. et al. (2005) J. Immunol. 174:3377.
  10. Krieg, C. et al. (2007) Nat. Immunol. 8:162.
  11. Bekiaris, V. et al. (2013) Immunity 39:1082.
  12. Cai G and Freeman GJ, (2009) Immunol Rev. 229:244
Long Name
B- And T-Lymphocyte Attenuator
Entrez Gene IDs
151888 (Human); 208154 (Mouse); 102144877 (Cynomolgus Monkey)
Alternate Names
B and T lymphocyte associated; B and T lymphocyte attenuator; B- and T-lymphocyte attenuator; B- and T-lymphocyte-associated protein; BTLA; BTLA1; CD272 antigen; CD272; FLJ16065; MGC129743

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Cynomolgus/Rhesus Macaque BTLA Fc Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Cynomolgus/Rhesus Macaque BTLA Fc Protein, CF and earn rewards!

Have you used Recombinant Cynomolgus/Rhesus Macaque BTLA Fc Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review